Can you provide the last earnings date for MINK THERAPEUTICS INC?
MINK THERAPEUTICS INC (INKT) last reported earnings on 3/31/2026.
NASDAQ:INKT • US6036932019
Past quarterly earnings results for MINK THERAPEUTICS INC (INKT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.56 | -0.84 | 33.64% | 10.48% | - | - | ||
| Q3 2025 | -0.65 | -0.87 | 25.47% | -30.00% | - | - | ||
| Q2 2025 | -1.06 | -0.56 | -90.10% | -51.43% | - | - | ||
| Q1 2025 | -0.70 | -0.62 | -12.50% | 36.36% | - | - | ||
| Q4 2024 | -0.62 | -0.51 | -21.57% | 61.25% | - | - | ||
| Q3 2024 | -0.50 | -0.82 | 38.73% | 66.67% | - | - | ||
| Q2 2024 | -0.70 | -1.02 | 31.37% | 61.11% | - | - | ||
| Q1 2024 | -1.10 | -1.56 | 29.67% | 35.29% | - | - | ||
| Q4 2023 | -1.60 | -1.56 | -2.30% | 30.43% | - | - | ||
| Q3 2023 | -1.50 | -1.86 | 19.42% | 21.05% | - | - | ||
| Q2 2023 | -1.80 | -2.01 | 10.65% | - | - | - | ||
| Q1 2023 | -1.70 | -2.42 | 29.82% | 26.09% | - | - | ||
| Q4 2022 | -2.30 | -2.14 | -7.38% | -27.78% | - | - | ||
| Q3 2022 | -1.90 | -2.37 | 19.88% | 67.80% | - | - | ||
| Q2 2022 | -1.80 | -2.45 | 26.47% | - | - | - | ||
| Q1 2022 | -2.30 | -2.11 | -9.11% | - | - | - | ||
| Q4 2021 | -1.80 | -4.18 | 56.96% | - | - | - | ||
| Q3 2021 | -5.90 | -2.09 | -182.16% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
MINK THERAPEUTICS INC (INKT) last reported earnings on 3/31/2026.
MINK THERAPEUTICS INC (INKT) beat EPS estimates and missed revenue estimates in the most recent quarter.